Vectans Pharma is delighted to collaborate with the Menarini group and Berlin Chemie for the commercialization of Sitavig® in Italy and Austria.
Vectans Pharma wishes you a happy and healthy New Year!
Dr Pierre Attali, our Chief Medical Officer, represented Vectans Pharma at the symposium organized by our Japanese partner Sosei Heptares about new treatments.
Vectans Pharma will be present at the CPhI worldwide in Frankfurt from November 01 to 03, 2022.
Vectans Pharma is delighted to collaborate withBerlin Chemie expanding the international scope of Sitavig® to 30 additional countries.
We are thrilled to welcome Medine Kockan as our new intern in Marketing and Strategic Innovation!
She will contribute to the many projects of our team. We are excited for her to participate in our continued growth!
Vectans Pharma will be present at the CPhI worldwide in Milan from November 9 to 11, 2021.
Copyright © VECTANS PHARMA